Serbia vs South-East Asia (WHO region): Treatment success rate for patients treated for MDR-TB
Serbia
100.0%
in 2022
South-East Asia (WHO region)
77.0%
in 2022
Serbia rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate for patients treated for MDR-TB over time
- Serbia
- South-East Asia (WHO region)
How they compare
Serbia currently reports 100.0% against 77.0% in South-East Asia (WHO region), a difference of 23.0%.
That makes Serbia's figure about 1.3 times South-East Asia (WHO region)'s.
Across all 12 years both countries report, Serbia has been ahead every year.
Serbia ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
Serbia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Serbia | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.0% | 54.0% | 6.0% | Serbia |
| 2010s | 67.8% | 51.2% | 16.5% | Serbia |
| 2020s | 100.0% | 73.0% | 27.0% | Serbia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Serbia or South-East Asia (WHO region)?
- Serbia, at 100.0% against 77.0% in South-East Asia (WHO region) as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Serbia and South-East Asia (WHO region)?
- 23.0%, with Serbia ahead.
- How many years of comparable data are there for Serbia and South-East Asia (WHO region)?
- 12 years are reported by both, from 2009 to 2022.
- How do Serbia and South-East Asia (WHO region) rank globally for treatment success rate for patients treated for mdr-tb?
- Serbia ranks 1st and South-East Asia (WHO region) ranks 2nd of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.